Can Substance Use Disorders be Managed Using the Chronic Care Model? Review and Recommendations from a NIDA Consensus Group.
Identifieur interne : 004374 ( PubMed/Corpus ); précédent : 004373; suivant : 004375Can Substance Use Disorders be Managed Using the Chronic Care Model? Review and Recommendations from a NIDA Consensus Group.
Auteurs : A Thomas Mclellan ; Joanna L. Starrels ; Betty Tai ; Adam J. Gordon ; Richard Brown ; Udi Ghitza ; Marc Gourevitch ; Jack Stein ; Marla Oros ; Terry Horton ; Robert Lindblad ; Jennifer McneelySource :
- Public health reviews [ 0301-0422 ] ; 2014.
Abstract
Brain imaging and genetic studies over the past two decades suggest that substance use disorders are best considered chronic illnesses. The passing of the Affordable Care Act in the United States has set the occasion for integrating treatment of substance use disorders into mainstream healthcare; and for using the proactive, team-oriented Chronic Care Model (CCM). This paper systematically examines and compares whether and how well the CCM could be applied to the treatment of substance use disorders, using type 2 diabetes as a comparator. The chronic illness management approach is still new in the field of addiction and research is limited. However comparative findings suggest that most proactive, team treatment-oriented clinical management practices now used in diabetes management are applicable to the substance use disorders; capable of being implemented by primary care teams; and should offer comparable potential benefits in the treatment of substance use disorders. Such care should also improve the quality of care for many illnesses now negatively affected by unaddressed substance abuse.
PubMed: 26568649
Links to Exploration step
pubmed:26568649Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Can Substance Use Disorders be Managed Using the Chronic Care Model? Review and Recommendations from a NIDA Consensus Group.</title><author><name sortKey="Mclellan, A Thomas" sort="Mclellan, A Thomas" uniqKey="Mclellan A" first="A Thomas" last="Mclellan">A Thomas Mclellan</name><affiliation><nlm:affiliation>The Treatment Research Institute, Philadelphia PA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Starrels, Joanna L" sort="Starrels, Joanna L" uniqKey="Starrels J" first="Joanna L" last="Starrels">Joanna L. Starrels</name><affiliation><nlm:affiliation>Albert Einstein College of Medicine and Monte ore Medical Center, Bronx, NY, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Tai, Betty" sort="Tai, Betty" uniqKey="Tai B" first="Betty" last="Tai">Betty Tai</name><affiliation><nlm:affiliation>National Institute of Health, National Institute on Drug Abuse, Bethesda, MD, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Gordon, Adam J" sort="Gordon, Adam J" uniqKey="Gordon A" first="Adam J" last="Gordon">Adam J. Gordon</name><affiliation><nlm:affiliation>University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Brown, Richard" sort="Brown, Richard" uniqKey="Brown R" first="Richard" last="Brown">Richard Brown</name><affiliation><nlm:affiliation>University of Wisconsin, School of Medicine and Public Health, Madison, WI, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Ghitza, Udi" sort="Ghitza, Udi" uniqKey="Ghitza U" first="Udi" last="Ghitza">Udi Ghitza</name><affiliation><nlm:affiliation>National Institute of Health, National Institute on Drug Abuse, Bethesda, MD, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Gourevitch, Marc" sort="Gourevitch, Marc" uniqKey="Gourevitch M" first="Marc" last="Gourevitch">Marc Gourevitch</name><affiliation><nlm:affiliation>New York University School of Medicine, Department of Population Health, New York, NY, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Stein, Jack" sort="Stein, Jack" uniqKey="Stein J" first="Jack" last="Stein">Jack Stein</name><affiliation><nlm:affiliation>National Institute of Health, National Institute on Drug Abuse, Bethesda, MD, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Oros, Marla" sort="Oros, Marla" uniqKey="Oros M" first="Marla" last="Oros">Marla Oros</name><affiliation><nlm:affiliation>The Mosaic Group, Baltimore MD. USA.</nlm:affiliation></affiliation></author><author><name sortKey="Horton, Terry" sort="Horton, Terry" uniqKey="Horton T" first="Terry" last="Horton">Terry Horton</name><affiliation><nlm:affiliation>Christiana Care Health System, Division of Addiction Medicine, Wilmington DE, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Lindblad, Robert" sort="Lindblad, Robert" uniqKey="Lindblad R" first="Robert" last="Lindblad">Robert Lindblad</name><affiliation><nlm:affiliation>The EMMES Corporation, Rockville, MD, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Mcneely, Jennifer" sort="Mcneely, Jennifer" uniqKey="Mcneely J" first="Jennifer" last="Mcneely">Jennifer Mcneely</name><affiliation><nlm:affiliation>New York University School of Medicine, Department of Population Health, New York, NY, USA.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:26568649</idno><idno type="pmid">26568649</idno><idno type="wicri:Area/PubMed/Corpus">004374</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">004374</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Can Substance Use Disorders be Managed Using the Chronic Care Model? Review and Recommendations from a NIDA Consensus Group.</title><author><name sortKey="Mclellan, A Thomas" sort="Mclellan, A Thomas" uniqKey="Mclellan A" first="A Thomas" last="Mclellan">A Thomas Mclellan</name><affiliation><nlm:affiliation>The Treatment Research Institute, Philadelphia PA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Starrels, Joanna L" sort="Starrels, Joanna L" uniqKey="Starrels J" first="Joanna L" last="Starrels">Joanna L. Starrels</name><affiliation><nlm:affiliation>Albert Einstein College of Medicine and Monte ore Medical Center, Bronx, NY, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Tai, Betty" sort="Tai, Betty" uniqKey="Tai B" first="Betty" last="Tai">Betty Tai</name><affiliation><nlm:affiliation>National Institute of Health, National Institute on Drug Abuse, Bethesda, MD, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Gordon, Adam J" sort="Gordon, Adam J" uniqKey="Gordon A" first="Adam J" last="Gordon">Adam J. Gordon</name><affiliation><nlm:affiliation>University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Brown, Richard" sort="Brown, Richard" uniqKey="Brown R" first="Richard" last="Brown">Richard Brown</name><affiliation><nlm:affiliation>University of Wisconsin, School of Medicine and Public Health, Madison, WI, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Ghitza, Udi" sort="Ghitza, Udi" uniqKey="Ghitza U" first="Udi" last="Ghitza">Udi Ghitza</name><affiliation><nlm:affiliation>National Institute of Health, National Institute on Drug Abuse, Bethesda, MD, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Gourevitch, Marc" sort="Gourevitch, Marc" uniqKey="Gourevitch M" first="Marc" last="Gourevitch">Marc Gourevitch</name><affiliation><nlm:affiliation>New York University School of Medicine, Department of Population Health, New York, NY, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Stein, Jack" sort="Stein, Jack" uniqKey="Stein J" first="Jack" last="Stein">Jack Stein</name><affiliation><nlm:affiliation>National Institute of Health, National Institute on Drug Abuse, Bethesda, MD, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Oros, Marla" sort="Oros, Marla" uniqKey="Oros M" first="Marla" last="Oros">Marla Oros</name><affiliation><nlm:affiliation>The Mosaic Group, Baltimore MD. USA.</nlm:affiliation></affiliation></author><author><name sortKey="Horton, Terry" sort="Horton, Terry" uniqKey="Horton T" first="Terry" last="Horton">Terry Horton</name><affiliation><nlm:affiliation>Christiana Care Health System, Division of Addiction Medicine, Wilmington DE, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Lindblad, Robert" sort="Lindblad, Robert" uniqKey="Lindblad R" first="Robert" last="Lindblad">Robert Lindblad</name><affiliation><nlm:affiliation>The EMMES Corporation, Rockville, MD, USA.</nlm:affiliation></affiliation></author><author><name sortKey="Mcneely, Jennifer" sort="Mcneely, Jennifer" uniqKey="Mcneely J" first="Jennifer" last="Mcneely">Jennifer Mcneely</name><affiliation><nlm:affiliation>New York University School of Medicine, Department of Population Health, New York, NY, USA.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Public health reviews</title><idno type="ISSN">0301-0422</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Brain imaging and genetic studies over the past two decades suggest that substance use disorders are best considered chronic illnesses. The passing of the Affordable Care Act in the United States has set the occasion for integrating treatment of substance use disorders into mainstream healthcare; and for using the proactive, team-oriented Chronic Care Model (CCM). This paper systematically examines and compares whether and how well the CCM could be applied to the treatment of substance use disorders, using type 2 diabetes as a comparator. The chronic illness management approach is still new in the field of addiction and research is limited. However comparative findings suggest that most proactive, team treatment-oriented clinical management practices now used in diabetes management are applicable to the substance use disorders; capable of being implemented by primary care teams; and should offer comparable potential benefits in the treatment of substance use disorders. Such care should also improve the quality of care for many illnesses now negatively affected by unaddressed substance abuse.</div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">26568649</PMID><DateCreated><Year>2015</Year><Month>11</Month><Day>16</Day></DateCreated><DateRevised><Year>2017</Year><Month>07</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0301-0422</ISSN><JournalIssue CitedMedium="Print"><Volume>35</Volume><Issue>2</Issue><PubDate><Year>2014</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Public health reviews</Title><ISOAbbreviation>Public Health Rev</ISOAbbreviation></Journal><ArticleTitle>Can Substance Use Disorders be Managed Using the Chronic Care Model? Review and Recommendations from a NIDA Consensus Group.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">http://www.journalindex.net/visit.php?j=6676</ELocationID><Abstract><AbstractText>Brain imaging and genetic studies over the past two decades suggest that substance use disorders are best considered chronic illnesses. The passing of the Affordable Care Act in the United States has set the occasion for integrating treatment of substance use disorders into mainstream healthcare; and for using the proactive, team-oriented Chronic Care Model (CCM). This paper systematically examines and compares whether and how well the CCM could be applied to the treatment of substance use disorders, using type 2 diabetes as a comparator. The chronic illness management approach is still new in the field of addiction and research is limited. However comparative findings suggest that most proactive, team treatment-oriented clinical management practices now used in diabetes management are applicable to the substance use disorders; capable of being implemented by primary care teams; and should offer comparable potential benefits in the treatment of substance use disorders. Such care should also improve the quality of care for many illnesses now negatively affected by unaddressed substance abuse.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McLellan</LastName><ForeName>A Thomas</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>The Treatment Research Institute, Philadelphia PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Starrels</LastName><ForeName>Joanna L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Albert Einstein College of Medicine and Monte ore Medical Center, Bronx, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tai</LastName><ForeName>Betty</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>National Institute of Health, National Institute on Drug Abuse, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gordon</LastName><ForeName>Adam J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University of Wisconsin, School of Medicine and Public Health, Madison, WI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghitza</LastName><ForeName>Udi</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>National Institute of Health, National Institute on Drug Abuse, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gourevitch</LastName><ForeName>Marc</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>New York University School of Medicine, Department of Population Health, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stein</LastName><ForeName>Jack</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>National Institute of Health, National Institute on Drug Abuse, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oros</LastName><ForeName>Marla</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The Mosaic Group, Baltimore MD. USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horton</LastName><ForeName>Terry</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Christiana Care Health System, Division of Addiction Medicine, Wilmington DE, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lindblad</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>The EMMES Corporation, Rockville, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McNeely</LastName><ForeName>Jennifer</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>New York University School of Medicine, Department of Population Health, New York, NY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Z99 DA999999</GrantID><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Public Health Rev</MedlineTA><NlmUniqueID>0370123</NlmUniqueID><ISSNLinking>0301-0422</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Am J Manag Care. 2011 Feb;17(2):144-50</RefSource><PMID Version="1">21473663</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Behav Pharmacol. 2009 Feb;20(1):1-17</RefSource><PMID Version="1">19179847</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Subst Abus. 2012;33(3):278-81</RefSource><PMID Version="1">22738005</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Intern Med. 1998 Sep 14;158(16):1789-95</RefSource><PMID Version="1">9738608</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Psychiatry. 2012 Aug;169(8):790-804</RefSource><PMID Version="1">22772364</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 1987 May 7;316(19):1174-80</RefSource><PMID Version="1">3574368</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Alcohol Clin Exp Res. 2007 Jan;31(1):64-8</RefSource><PMID Version="1">17207103</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Fam Med. 2011 Jan-Feb;9(1):12-21</RefSource><PMID Version="1">21242556</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Gen Psychiatry. 2007 May;64(5):566-76</RefSource><PMID Version="1">17485608</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Pain Med. 2005 Mar-Apr;6(2):107-12</RefSource><PMID Version="1">15773874</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Intern Med. 2003 Mar 4;138(5):372-82</RefSource><PMID Version="1">12614089</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JAMA. 2000 Oct 4;284(13):1689-95</RefSource><PMID Version="1">11015800</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Obstet Gynecol. 2012 Jan;119(1):102-10</RefSource><PMID Version="1">22183217</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diabetes Educ. 2009 Sep-Oct;35(5):761-9</RefSource><PMID Version="1">19622716</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JAMA. 2004 Mar 10;291(10):1238-45</RefSource><PMID Version="1">15010446</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Health Aff (Millwood). 2011 Aug;30(8):1402-10</RefSource><PMID Version="1">21821557</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Soc Sci Med. 2001 Mar;52(6):863-70</RefSource><PMID Version="1">11234861</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Intern Med. 2005 May 9;165(9):986-95</RefSource><PMID Version="1">15883236</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Fam Med. 2010 Jul-Aug;8(4):308-15</RefSource><PMID Version="1">20644185</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Nat Neurosci. 2005 Nov;8(11):1429-30</RefSource><PMID Version="1">16251981</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Mayo Clin Proc. 2008 Jul;83(7):747-57</RefSource><PMID Version="1">18613991</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Intern Med. 1999 Aug 9-23;159(15):1681-9</RefSource><PMID Version="1">10448769</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JAMA. 2009 Mar 25;301(12):1242-52</RefSource><PMID Version="1">19318652</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Prev Med. 2003 Jul;37(1):23-32</RefSource><PMID Version="1">12799126</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Intern Med. 2011 Mar 14;171(5):425-31</RefSource><PMID Version="1">21403039</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Ann Intern Med. 2004 Feb 3;140(3):211-9</RefSource><PMID Version="1">14757619</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Diabetes Res Clin Pract. 2011 Jan;91(1):1-12</RefSource><PMID Version="1">20655610</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Subst Abuse Treat. 2009 Apr;36(3):244-51</RefSource><PMID Version="1">18715741</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JAMA. 2002 Oct 16;288(15):1909-14</RefSource><PMID Version="1">12377092</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Arch Gen Psychiatry. 2005 Feb;62(2):199-207</RefSource><PMID Version="1">15699297</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Clin Psychol. 2006 Jun;62(6):735-50</RefSource><PMID Version="1">16538654</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Addiction. 2008 Jun;103(6):1039-47</RefSource><PMID Version="1">18373724</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Psychiatr Serv. 2006 Jan;57(1):37-47</RefSource><PMID Version="1">16399961</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Health Serv Res. 2012 Dec;47(6):2137-58</RefSource><PMID Version="1">22578085</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Med Care Res Rev. 2010 Aug;67(4):476-84</RefSource><PMID Version="1">20519426</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Biol Psychiatry. 2012 Dec 1;72(11):890-1</RefSource><PMID Version="1">23121867</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Alcohol Clin Exp Res. 2005 Jul;29(7):1190-7</RefSource><PMID Version="1">16046874</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Public Health. 2006 Nov;96(11):2016-23</RefSource><PMID Version="1">17018819</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2011 Sep 1;365(9):825-33</RefSource><PMID Version="1">21879900</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BMJ. 2008 Nov 04;337:a2038</RefSource><PMID Version="1">18984632</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Substance use disorders</Keyword><Keyword MajorTopicYN="N">chronic care model</Keyword><Keyword MajorTopicYN="N">chronic illness</Keyword><Keyword MajorTopicYN="N">electronic health records</Keyword><Keyword MajorTopicYN="N">healthcare reform</Keyword><Keyword MajorTopicYN="N">type 2 diabetes management</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>11</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26568649</ArticleId><ArticleId IdType="pmc">PMC4643942</ArticleId><ArticleId IdType="mid">NIHMS593880</ArticleId></ArticleIdList><pmc-dir>nihms</pmc-dir>
</PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Amérique/explor/PittsburghV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004374 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 004374 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Amérique
|area= PittsburghV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:26568649
|texte= Can Substance Use Disorders be Managed Using the Chronic Care Model? Review and Recommendations from a NIDA Consensus Group.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:26568649" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a PittsburghV1
| This area was generated with Dilib version V0.6.38. |  |